University Hospital 12 de Octubre

Our principal aims are to study the genetics of the Spanish ALS population, to discover new prognostic and diagnostic biomarkers, and to develop preclinical and clinical assays.

Contact
Location
University Hospital 12 de Octubre, Avenida de Córdoba, Madrid, Spain
Contact

Specialists

Jesús Esteban Pérez

Principal investigator

Dr. Jesús Esteban Pérez is Principal investigator in University Hospital 12 de […]

Jesús Esteban Pérez
Current trials
Recruiting
Phase iii

ALXN1210-ALS-308 trial

Industry trial
This phase 3 trial aims to study the safety and efficacy of the drug ‘ravulizumab’ in people living with ALS. To register for this study, you should contact your local ALS centre or treating physician.
Read more
Recruiting
Phase iii

VALOR study

Industry trial
Biogen is conducting a clinical trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS) with a SOD1 gene mutation.
Read more
In preparation
Phase iii

The Lighthouse 2 trial

Investigator initiated trial
The Lighthouse 2 study is a phase 3 clinical trial in which we will investigate the efficacy of the drug Triumeq.
Read more
In preparation
Phase iii

MAGNET

Platform trial
MAGNET is an innovative clinical platform trial in which multiple treatments for ALS are investigated simultaneously.
Read more
Recruiting
Phase iii

TUDCA-ALS

Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more